Stock Movers
Stock Movers

Aug 28, 2026 · 7 min

PayPal deal collapse rattles fintech as Affirm gains

Paypal Sinks on Abandoned Deal, Affirm Rallies, BioNTech Slumps

The episode captures how abandoned dealmaking, consumer-credit signals, and a clinical setback are reshaping sentiment across fintech and biotech.

3 key takeaways
  1. 1PayPal shares fell after Advent and Stripe abandoned a potential buyout valued at more than $50 billion.
  2. 2Affirm rallied on a stronger revenue forecast, earnings growth, and continued expansion of its Shopify partnership.
  3. 3BioNTech declined after ending a personalized mRNA cancer-vaccine trial with Roche despite renewed enthusiasm for mRNA treatments.

Don't miss

PayPal’s shares fall after Advent and Stripe abandon a potential acquisition worth more than $50 billion.

The brief

PayPal shares sank after Advent and Stripe abandoned a potential acquisition valued at more than $50 billion, reviving questions about the company’s strategic direction.

Affirm moved higher after issuing a stronger first-quarter revenue forecast and reporting substantial earnings growth, while management said customers remained healthy despite tighter lending.

BioNTech shares fell after it and Roche discontinued an advanced trial of a personalized mRNA cancer vaccine, a setback arriving amid renewed investor interest in mRNA treatments.

The closing preview shifts from market movers to urban growth, examining how AI, long-term planning, and infrastructure blueprints could help cities manage rapid population increases.

What was said on this episode

6 statements · 4 positive · 2 negative

  1. Tatiana Dariaon AffirmPositive2:11

    Affirm has reported substantial earnings growth.

    “But it has also posted huge earnings growth.”

    Listen at 2:11

  2. Tatiana Dariaon BioNTech personalized mRNA cancer vaccineNegative3:33

    BioNTech’s terminated cancer-vaccine trial represents a significant setback.

    “this is a real setback”

    Listen at 3:33

  3. Tatiana Dariaon mRNAPositive3:46

    Positive melanoma results raised hopes for mRNA treatments beyond COVID-19.

    “it raised hopes about the mRNA's second act here after COVID.”

    Listen at 3:46

  4. Tatiana Dariaon mRNA technology in solid tumorsNegative3:51

    BioNTech’s setback raises doubts about mRNA technology in solid tumors.

    “this is raising real questions about can this technology work in other tumors, particularly solid tumors”

    Listen at 3:51

  5. Rohit Kumaron AI in smart citiesPositive5:14

    AI will accelerate processes in smart-city systems.

    “AI will allow in the smart city space to compress a lot of things. the speed will change.”

    Listen at 5:14

  6. Estefanía Tapiason DubaiPositive5:40

    Dubai responded effectively to population growth and has long-term urban planning.

    “they reacted very well to it. They have a long-term urban planning vision”

    Listen at 5:40

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Books & mentions

Weekly email

State of the Pod, every Monday

The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.

Listen to the full episode and explore every guest, topic, and moment on PodLume.